Table 1.
General scheme of the study
Phase A | Phase B | ||||
Randomisation | |||||
by cages | ![]() |
![]() |
|||
within cages by treatments | - | ![]() |
|||
Blinding | |||||
Treatment administration | - | ![]() |
|||
Edema measurement | ![]() |
![]() |
|||
Inflammation model | CA | BL | CA | ||
Homeopathic remedies | |||||
dilution | n. of animals studied | ||||
Arnica | D4 | 71 | O/I | O/I | - |
Apis | D4 | 90 | O/I | O/I | O |
Apis | D30 | 18 | - | - | O |
Atropa | D4 | 72 | O/I | O/I | - |
Hamamelis | D4 | 72 | O/I | O/I | - |
Lachesis | D6 | 86 | O/I | O/I | O |
Lachesis | D30 | 18 | - | - | O |
Phosphorus | D6 | 90 | O/I | O/I | O |
Phosphorus | D30 | 18 | - | - | O |
Reference treatments | |||||
Placebo: | |||||
Physiological solution | 86 | O/I | O/I | O | |
Active comparator: | |||||
Indomethacin | 88 | I/I | I/I | I |
O = oral administration
I = administration through injection
CA = carrageenan induced edema
BL = autologous blood induced edema
Each treatment group has been tested through 3 replications. In each replication 6 rats were studied. In experiment A 11 rats were excluded from the analyses because of problems with edema induction.